According to Genetic Technologies's latest financial reports and stock price the company's current Operating Margin is -156.78%. At the end of 2024 the company had an Operating Margin of -156.78%.
Year | Operating Margin | Change |
---|---|---|
2024 | -156.78% | 14.35% |
2023 | -137.11% | 30.06% |
2022 | -105.42% | -98.2% |
2021 | -5,870.91% | -90.8% |
2020 | -63,815.64% | 152.7% |
2019 | -25,253.91% | 774.73% |
2018 | -2,887.06% | 78.13% |
2017 | -1,620.78% | 57.99% |
2016 | -1,025.84% | 134.26% |
2015 | -437.90% | 97.22% |
2014 | -222.04% | -19.8% |
2013 | -276.84% | 92.92% |
2012 | -143.50% | -849.47% |
2011 | 19.15% | -109.6% |
2010 | -199.40% | 175.78% |
2009 | -72.30% | 106.56% |
2008 | -35.00% | 235.52% |
2007 | -10.43% | -80.57% |
2006 | -53.71% | -29.66% |
2005 | -76.35% | -57.62% |
2004 | -180.17% | 895.39% |
2003 | -18.10% | -93.76% |
2002 | -289.92% | 19.06% |
2001 | -243.50% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Eterna Therapeutics ERNA | -6,475.42% | 4,030.26% | ๐บ๐ธ USA |
![]() Myriad Genetics MYGN | -14.74% | -90.60% | ๐บ๐ธ USA |
![]() LabCorp LH | 7.37% | -104.70% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | 11.66% | -107.44% | ๐บ๐ธ USA |
![]() Compugen CGEN | -34.77% | -77.82% | ๐ฎ๐ฑ Israel |
![]() Danaher DHR | 19.45% | -112.41% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | 16.47% | -110.51% | ๐บ๐ธ USA |
![]() Neogen NEOG | -56.10% | -64.22% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.